Brennan Kevin M.

CIK 00019713031 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001971303

Recent Transactions

20 trades

Sale
Xilio Therapeutics, Inc.$XLO
Common Stock
2026-01-02$0.64/sh−1,826→ 6,371 total
Exercise/Conversion
Xilio Therapeutics, Inc.$XLO
Common Stock
2026-01-01+5,000→ 8,197 total
Exercise/Conversion
Xilio Therapeutics, Inc.$XLO
Restricted Stock Units
2026-01-01−5,000→ 10,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-12-31+95,221→ 95,221 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+20,000→ 20,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+55,000→ 55,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+25,000→ 25,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+131,700→ 131,700 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−55,000→ 0 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−25,000→ 0 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−20,000→ 0 total
Sale
Xilio Therapeutics, Inc.$XLO
Common stock
2025-01-02$0.98/sh−1,803→ 3,197 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-01-01+60,000→ 60,000 total
Exercise/Conversion
Xilio Therapeutics, Inc.$XLO
Common Stock
2025-01-01+5,000→ 5,000 total
Exercise/Conversion
Xilio Therapeutics, Inc.$XLO
Restricted Stock Units
2025-01-01−5,000→ 15,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2024-10-01+26,000→ 26,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2024-05-01+20,000→ 20,000 total
Award
Xilio Therapeutics, Inc.$XLO
Restricted Stock Units
2024-01-01+20,000→ 20,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2023-08-16+25,000→ 25,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2023-04-01+55,000→ 55,000 total

Companies

Xilio Therapeutics, Inc.
SVP, FINANCE AND ACCOUNTING
$XLO

Recent Filings

Address

828 WINTER STREET SUITE 300

WALTHAM, MA, 02451

View on SEC.gov